Deutsche Bank AG halted bonus payments to a group of employees while examining whether they improperly traded with the firm.
“We are reviewing a transaction that may have involved unacceptable conflicts of interest,” the Frankfurt-based company said in an e-mailed statement, without identifying past or present staff involved. “We will take disciplinary measures where appropriate and review further our controls to minimize the chance of a re-occurrence.”
The internal review focuses on Deutsche Bank’s efforts in 2009 to profit from differences in prices of credit indices and the underlying debts that compose them, according to a person with knowledge of the situation.
Six employees participated in their personal accounts alongside an external hedge fund, the person said.
The bank began scrutinizing the trading last year after it was flagged amid a broad push to reduce leverage, the person said.
Internal auditors estimate the current and former employees made about US$37 million on the transactions, the Wall Street Journal wrote in a report on Thursday.
A former senior executive in the group may stand to reap US$9 million on an about US$1 million investment, the newspaper said.
It cited a spokesman for the banker as saying he had “fulfilled all appropriate compliance procedures, been entirely transparent at all times and denied any wrongdoing.”
Auditors have not determined whether Deutsche Bank lost money once related transactions are considered, the Journal cited an unidentified person briefed on the matter as saying.
However, excluding such ancillary revenue, a preliminary assessment shows the deal might have cost the firm more than US$60 million, the publication said.
The bank’s investigation also examines the original rationale and approval process for the transaction, as well as how the deal was supervised, the person said.
“Based on our findings to date, we believe that no client was disadvantaged by this transaction,” Deutsche Bank said in a statement.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained